Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.57 |
| ▸ | TFPI | P10646 | 6/20 | 0.54 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.54 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.54 |
| ▸ | CALCR | P30988 | 4/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.53 |
| ▸ | F2 | P00734 | 2/20 | 0.52 |
| ▸ | KDM1A | O60341 | 1/20 | 0.52 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29707431 | 0.89 | MC4R (0.62) | TFPIRAMP3CALCRKDM1ANPY1R | |
| SCHEMBL29721233 | 0.87 | APLNR (0.57) | APLNRCALCRKEAP1F2KDM1A | |
| SCHEMBL30607386 | 0.87 | MC4R (0.61) | APLNRTFPIRAMP3CALCRF2 | |
| SCHEMBL30883205 | 0.86 | F2 (0.61) | APLNRTFPIRAMP3CALCRF2 | |
| SCHEMBL31696781 | 0.86 | CALCR (0.65) | APLNRTFPIRAMP3CALCRNPY1R | |
| SCHEMBL29700297 | 0.86 | APLNR (0.66) | APLNRTFPICALCRF2KDM1A | |
| SCHEMBL31182755 | 0.85 | CALCR (0.60) | APLNRRAMP3CALCRKEAP1F2 | |
| SCHEMBL30495765 | 0.85 | NPY2R (0.64) | TFPICALCRKDM1ANPY1RNPY2R | |
| SCHEMBL30141845 | 0.85 | APLNR (0.68) | APLNRTFPICALCRF2KDM1A | |
| SCHEMBL29749731 | 0.85 | APLNR (0.68) | APLNRTFPICALCRF2KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230040544-A1 | COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) | SAREPTA THERAPEUTICS, INC. | 2023-02-09 | — | — | US | disclosed |